HBAN Stock Analysis: Helvetia Holding | SW
Insurance - Diversified | SW, Switzerland | Market Cap: 21.457m CHF | 12M Return: 15.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 24.5M
Rev. Trend: -43.5%
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Helvetia Baloise Holding AG is a Swiss-based insurance company offering life, non-life, and reinsurance products across European and international markets. Its life insurance portfolio includes investment-linked, group life, and traditional individual life policies, while its non-life operations cover property, motor vehicle, health/accident, liability, engineering, and transport insurance. The company also provides specialty lines such as marine, aviation, and art insurance, alongside savings, endowment, annuity products, pension plans, and asset management services.
Geographically, Helvetia operates in Switzerland, Spain, Germany, Belgium, Luxembourg, Italy, Austria, and France, with additional international activities. Diversified insurance carriers like Helvetia typically generate revenue from underwriting premiums and investment income earned on float, while profitability is often measured through combined ratios and return on equity metrics specific to the insurance sector.
The company was incorporated in 2017 and is headquartered in Basel, Switzerland. It was formerly known as Helvetia Holding AG before adopting its current name in April 2022, reflecting the combination with Baloise.
- European non-life premium growth accelerates in Spain and Italy
- Higher interest rates lift investment income on life insurance portfolio
- Baloise merger cost synergies exceed integration expense targets
| Net Income: 967.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.13 > 1.0 |
| NWC/Revenue: -488.3% < 20% (prev 16.41%; Δ -504.7% < -1%) |
| CFO/TA 0.01 > 3% & CFO 1.35b > Net Income 967.0m |
| Net Debt (95.1m) to EBITDA (1.39b): 0.07 < 3 |
| Current Ratio: 0.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (53.5m) vs 12m ago 1.19% < -2% |
| Gross Margin: 57.58% > 18% (prev 105.5%; Δ -47.95% > 0.5%) |
| Asset Turnover: 18.36% > 50% (prev 34.75%; Δ -16.39% > 0%) |
| Interest Coverage Ratio: 10.51 > 6 (EBIT TTM 1.11b / Interest Expense TTM 105.3m) |
| A: -0.63 (Total Current Assets 4.53b - Total Current Liabilities 97.5b) / Total Assets 146b |
| B: 0.03 (Retained Earnings 3.85b / Total Assets 146b) |
| C: 0.01 (EBIT TTM 1.11b / Avg Total Assets 104b) |
| D: 0.10 (Book Value of Equity 13.5b / Total Liabilities 133b) |
| Altman-Z'' = -3.90 = D |
As of July 28, 2026, the stock is trading at CHF 215.80 with a total of 86,288 shares traded. Over the past week, the price has changed by +1.79%, over one month by +3.75%, over three months by +4.40% and over the past year by +15.44%.
Current recommended Stop Loss: 211.70 (which is 1.9% or 1.4 ATR below the current price).
Helvetia Holding has no consensus analysts rating.
P/E Trailing = 20.8671
P/E Forward = 11.5207
P/S = 2.0789
P/B = 1.6424
P/EG = 0.9772
Revenue TTM = 19.0b CHF
EBIT TTM = 1.11b CHF
EBITDA TTM = 1.39b CHF
Long Term Debt = 4.39b CHF (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 4.63b CHF (from shortLongTermDebtTotal, last quarter) + Leases 120.4m
Net Debt = 95.1m CHF (calculated: Debt 4.63b - CCE 4.53b)
Enterprise Value = 21.6b CHF (21.5b + Debt 4.63b - CCE 4.53b)
Interest Coverage Ratio = 10.51 (Ebit TTM 1.11b / Interest Expense TTM 105.3m)
EV/FCF = 20.21x (Enterprise Value 21.6b / FCF TTM 1.07b)
FCF Yield = 4.95% (FCF TTM 1.07b / Enterprise Value 21.6b)
FCF Margin = 5.60% (FCF TTM 1.07b / Revenue TTM 19.0b)
Net Margin = 5.08% (Net Income TTM 967.0m / Revenue TTM 19.0b)
Gross Margin = 57.58% ((Revenue TTM 19.0b - Cost of Revenue TTM 8.08b) / Revenue TTM)
Gross Margin QoQ = -3.71% (prev none%)
Tobins Q-Ratio = 0.15 (Enterprise Value 21.6b / Total Assets 146b)
Interest Expense / Debt = 2.28% (Interest Expense 105.3m / Debt 4.63b)
Taxrate = 20.18% (247.3m / 1.23b)
NOPAT = 883.8m (EBIT 1.11b * (1 - 20.18%))
Current Ratio = 0.05 (Total Current Assets 4.53b / Total Current Liabilities 97.5b)
Debt / Equity = 0.34 (Debt 4.63b / totalStockholderEquity, last quarter 13.5b)
Debt / EBITDA = 0.07 (Net Debt 95.1m / EBITDA 1.39b)
Debt / FCF = 0.09 (Net Debt 95.1m / FCF TTM 1.07b)
Total Stockholder Equity = 6.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.93% (Net Income 967.0m / Total Assets 146b)
RoE = 15.14% (Net Income TTM 967.0m / Total Stockholder Equity 6.38b)
RoCE = 10.28% (EBIT 1.11b / Capital Employed (Equity 6.38b + L.T.Debt 4.39b))
RoIC = 1.84% (NOPAT 883.8m / Invested Capital 48.0b)
WACC = 5.50% (E(21.5b)/V(26.1b) * Re(6.29%) + D(4.63b)/V(26.1b) * Rd(2.28%) * (1-Tc(0.20)))
Discount Rate = 6.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 80.90 | Cagr: 0.55%
[DCF] Terminal Value 77.97% ; FCFF base≈849.4m ; Y1≈973.7m ; Y5≈1.43b
[DCF] Fair Price = 216.7 (EV 21.6b - Net Debt 95.1m = Equity 21.5b / Shares 99.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
Revenue Correlation: -43.48 | Revenue CAGR: -13.19% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=11.32 | Chg30d=+0.00% | Revisions=-40% | GrowthEPS=-0.7% | GrowthRev=+38.8%
EPS next Year (2027-12-31): EPS=12.94 | Chg30d=+0.00% | Revisions=-17% | GrowthEPS=+14.3% | GrowthRev=+15.1%
[Analyst] Revisions Ratio: -38% (up=1, down=4)